CStone Pharmaceuticals Share Price OTC Markets
Stocks
CSPHF
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7100 USD | +19.43% |
|
0.00% | -20.49% |
| Market Cap | 625.93Cr 92Cr 81Cr 74Cr 69Cr 129.37Cr 8.89TCr 132.25Cr 890.07Cr 350.09Cr 4.36TCr 346.8Cr 339.19Cr 15TCr | P/E 2026 * |
-294x | P/E 2027 * | 5.85x |
|---|---|---|---|---|---|
| Enterprise Value | 573.11Cr 85Cr 74Cr 68Cr 63Cr 118.46Cr 8.14TCr 121.09Cr 814.96Cr 320.54Cr 3.99TCr 317.53Cr 310.57Cr 14TCr | EV / Sales 2026 * |
12x | EV / Sales 2027 * | 1.55x |
| Free-Float |
77.71% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | +19.43% | ||
| Current month | +19.43% | ||
| 1 month | +19.43% | ||
| 3 months | -29.70% | ||
| 6 months | -17.29% | ||
| Current year | -20.49% |
| 1 month | 0.71 |  | 0.71 |
| Current year | 0.59 | | 1.01 |
| 1 year | 0.59 | | 1.01 |
| 3 years | 0.11 | | 1.01 |
| 5 years | 0.11 | | 1.95 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +19.43% | 0.00% | - | - | 92Cr | |
| -0.33% | +1.83% | +24.73% | -5.89% | 6.88TCr | |
| +0.46% | +2.04% | +38.72% | +192.88% | 5.21TCr | |
| +0.94% | +39.60% | +39.60% | +39.60% | 4.35TCr | |
| -0.58% | +1.05% | -51.98% | -53.78% | 4.12TCr | |
| -1.40% | +3.43% | +64.81% | -25.61% | 3.04TCr | |
| -2.11% | -9.45% | +97.76% | -50.61% | 2.45TCr | |
| +0.51% | +0.46% | +72.78% | +86.41% | 2.34TCr | |
| +3.99% | +3.82% | +4.34% | +196.00% | 1.98TCr | |
| +0.06% | +0.04% | +71.52% | +125.73% | 1.66TCr | |
| Average | +2.62% | -0.58% | +40.25% | +56.08% | 3.56TCr | |
| Weighted average by Cap. | +0.55% | +0.08% | +33.22% | +47.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48Cr 7.07Cr 6.18Cr 5.7Cr 5.26Cr 9.91Cr 680.99Cr 10Cr 68Cr 27Cr 333.52Cr 27Cr 26Cr 1.15TCr | 171.33Cr 25Cr 22Cr 20Cr 19Cr 35Cr 2.43TCr 36Cr 243.63Cr 96Cr 1.19TCr 95Cr 93Cr 4.1TCr |
| Net income | -24Cr -3.59Cr -3.14Cr -2.89Cr -2.67Cr -5.03Cr -345.53Cr -5.14Cr -35Cr -14Cr -169.23Cr -13Cr -13Cr -582.56Cr | 69Cr 10Cr 8.86Cr 8.18Cr 7.54Cr 14Cr 976.68Cr 15Cr 98Cr 38Cr 478.34Cr 38Cr 37Cr 1.65TCr |
| Net Debt | -53Cr -7.79Cr -6.81Cr -6.28Cr -5.79Cr -11Cr -750.44Cr -11Cr -75Cr -30Cr -367.54Cr -29Cr -29Cr -1.27TCr | -360.31Cr -53Cr -46Cr -43Cr -40Cr -74Cr -5.12TCr -76Cr -512.37Cr -201.53Cr -2.51TCr -199.63Cr -195.25Cr -8.63TCr |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
Select your edition
All financial news and data tailored to specific country editions
